Equities

Poolbeg Pharma PLC

POLB:LSE

Poolbeg Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4.60
  • Today's Change0.20 / 4.55%
  • Shares traded2.55m
  • 1 Year change-10.68%
  • Beta2.0717
Data delayed at least 20 minutes, as of Feb 06 2026 16:42 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2024, cash reserves at Poolbeg Pharma PLC fell by 4.35m. However, Cash Flow from Investing totalled 299.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.65m for operations while cash from financing was breakeven.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0171
Tangible book value per share0.0147
More ▼

Balance sheet in GBPView more

Poolbeg Pharma PLC appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio24.94
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.